USANA Philippines Earns Three Major Awards for Corporate Excellence
MANILA, Philippines, Sept. 23, 2022 /PRNewswire/ -- USANA Health Sciences, Inc., a leader in global nutrition, applauds its Philippines market for being recently honored with three regional awards. Two from the Asia Responsible Enterprise Awards (AREA) and one from HR Asia Best Companies to Work. To find out more about USANA and...
Shandong Proton Center Celebrates Milestone in Delivering High-Quality Proton Treatment
BEIJING, Sept. 23, 2022 /PRNewswire/ -- On July 20, 2022, the Shandong Proton Center (SDPT) treated the first four participants enrolled in a clinical trial, marking a key milestone on the path to expanding access to advanced cancer care – including proton therapy – in China. Proton therapy can be used to treat many of the most common types...
WINNERS OF THE 2023 BREAKTHROUGH PRIZES IN LIFE SCIENCES, MATHEMATICS AND FUNDAMENTAL PHYSICS ANNOUNCED
$15.75 Million in Prizes Awarded for Predicting Protein Structure with Deep Learning, Pioneering Field of Quantum Information, and Discoveries with Applications from Treating Neurodegenerative Disease to Optimizing Video Transmission Breakthrough Prize in Life Sciences Awarded to Clifford P. Brangwynne and Anthony A. Hyman; Demis Hassabis and John Jumper; Emmanuel Mignot and Masashi Yanagisawa Breakthrough Prize in Mathematics Awarded to Daniel...
Frost & Sullivan Explores the Growing Impact of the Digital Front Door on Healthcare
Digital front door creates a new, consumer-centric paradigm in healthcare while improving patient satisfaction SAN ANTONIO, Sept. 22, 2022 /PRNewswire/ -- In just a few short years, the digital front door has shifted from being a nice-to-have online presence to being a critical part of every healthcare organization's overarching digital health strategy. Extending well beyond a website, the digital...
NIA Accelerates Thai FoodTech Startups to Steer Bangkok Towards Becoming FoodTech Silicon Valley Through SPACE-F Project
BANGKOK, Sept. 22, 2022 /PRNewswire/ -- The National Innovation Agency (Public Organization), Thailand or NIA continues its support in scaling up the FoodTech startups through the 2022 edition of the "SPACE-F" project. With aims to encourage investment opportunities for the Thai food sector and encounter global food security crisis, the agency targets to stimulate the use of deep tech...
Clarivate Supports Peer Review Week by Raising the Profile of Peer Reviewers
Recognizing peer review via the next generation of Web of Science Researcher Profiles LONDON, Sept. 22, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today celebrates Peer Review Week with the announcement of new services for authors to better track...
Agilis Robotics Targeting its Pre-B Round Fund-raising to be Completed by 2022
Successful In Vivo Testing Clears the Way for First Human Trial in Near Future HONG KONG, Sept. 22, 2022 /PRNewswire/ -- Agilis Robotics Limited ("Agilis Robotics" or the "Company"), the creator of the first surgical robotic instruments in Hong Kong to target endoscopic submucosal dissection (ESD) and en bloc resection of bladder tumour (ERBT) procedures, has announced its fund-raising status,...
Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0803 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
-- CK0803 are neurotropic, allogeneic, umbilical cord blood derived T regulatory (Treg) cells -- CK0803 represents the company's fifth program to receive IND Clearance utilizing Cellenkos' proprietary CRANE™ technology HOUSTON, Sept. 22, 2022 /PRNewswire/ -- Cellenkos, Inc., a clinical stage biotech company that focuses on developing transformative cellular therapeutics for treatment of...
China CDE Grants CMG901 Breakthrough Therapy Designation for Claudin 18.2-Positive Advanced Gastric & Gastroesophageal Junction Cancer
CHENGDU, China, Sept. 22, 2022 /PRNewswire/ -- Keymed Biosciences (HKEX:02162) announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has granted CMG901 the Breakthrough Therapy Designation for the treatment of advanced gastric and gastroesophageal junction(GEJ) cancer which have relapsed and/or are intolerant to prior therapies. About CMG901 CMG901 is a Claudin 18.2-targeted antibody-drug conjugate...
RVAC Medicines Initiates First-in-Human Clinical Trials for mRNA COVID-19 Vaccine Candidates
SINGAPORE, Sept. 22, 2022 /PRNewswire/ -- RVAC Medicines Pte. Ltd., a messenger RNA (mRNA) technology platform company incubated by CBC Group in 2021, announced today that a participant has been dosed in a Phase 1, first-in-human study evaluating the company's mRNA-based COVID-19 vaccine candidate, RVM-V001. The Phase 1 study is an open-label, dose escalation study to evaluate the safety...
